Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungwon Kim

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancerAthanassios Argiris, Dwight E Heron, Ryan P Smith, et al.
Immunity|January 12, 2020
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck CancerAnthony R Cillo, Cornelius H L Kürten, Tracy Tabib, et al.
Clinical and Translational Radiation Oncology|March 26, 2026
Outcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)Kasey R Cargill, Phillip M Pifer, John A Vargo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2023
Incidence of Health Facility Switching and Associations With HIV Viral Rebound Among Persons on Antiretroviral Therapy in Uganda: A Population-based StudyJoseph G Rosen, Anthony Ndyanabo, Hadijja Nakawooya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancerBradley A Schiff, Andrea B McMurphy, Samar A Jasser, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local ControlJessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck CancerRobert L Ferris, Jessica Moskovitz, Sheryl Kunning, et al.
Laryngoscope Investigative Otolaryngology|June 23, 2022
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasisSteven Borson, Yongli Shuai, Barton F Branstetter, et al.
Cancer|June 8, 2019
Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stageShaum Sridharan, Lester D R Thompson, Bibianna Purgina, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Increasing intra- and inter-subtype HIV diversity despite declining HIV incidence in UgandaSeungwon Kim, Godfrey Kigozi, Michael A Martin, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancerAthanassios Argiris, Dwight E Heron, Ryan P Smith, et al.
Immunity|January 12, 2020
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck CancerAnthony R Cillo, Cornelius H L Kürten, Tracy Tabib, et al.
Clinical and Translational Radiation Oncology|March 26, 2026
Outcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)Kasey R Cargill, Phillip M Pifer, John A Vargo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2023
Incidence of Health Facility Switching and Associations With HIV Viral Rebound Among Persons on Antiretroviral Therapy in Uganda: A Population-based StudyJoseph G Rosen, Anthony Ndyanabo, Hadijja Nakawooya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancerBradley A Schiff, Andrea B McMurphy, Samar A Jasser, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local ControlJessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck CancerRobert L Ferris, Jessica Moskovitz, Sheryl Kunning, et al.
Laryngoscope Investigative Otolaryngology|June 23, 2022
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasisSteven Borson, Yongli Shuai, Barton F Branstetter, et al.
Cancer|June 8, 2019
Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stageShaum Sridharan, Lester D R Thompson, Bibianna Purgina, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Increasing intra- and inter-subtype HIV diversity despite declining HIV incidence in UgandaSeungwon Kim, Godfrey Kigozi, Michael A Martin, et al.
Pageof 15